Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Why healthcare and acquisitions have been the place to be during a pandemic

  • In Opinion
  • January 12, 2022
  • Jarryd Russell
Why healthcare and acquisitions have been the place to be during a pandemic

When the market crashed in March 2020, the world economy saw its biggest fall since the GFC. Few would have anticipated a recovery within just 12 months, however that’s exactly what happened with governments jumping on the front foot with stimulus packages.

For Australia, it enabled the All Ordinaries to recover to its pre-pandemic levels (7200) in 12 months. Since then, it has continued climbing to now be trading around 7600. What made the recovery more impressive was the fact it took 12 years for the All Ordinaries to return to its pre-GFC level of 6500 in May 2019.

Comparatively, the impact of the pandemic and the majority of the world working from home; was just a blip on the economy. In many instances, COVID-19 strengthened the corporate world where operational expenses were slashed and employees produced more output but with a much healthier work-life balance.

As would be expected in response to a pandemic, the S&P/ASX 200 Healthcare Index (ASX: XHJ, +13.6%) has outperformed the ASX200 (ASX: XJO), +7.36%) since the commencement of the pandemic.

In that same time, we have seen Healthia (ASX: HLA) blitz both indexes to emerge as Australia’s fastest growing allied health portfolio, to deliver a 99% gain in HLA’s share price.
Healthia has benefited from industry tailwinds where its services have throughout the pandemic been classified as ‘vital community services’ ensuring minimal disruption to its operations.

That said, the strong gains have been accentuated via Healthia’s growth strategy by acquisition coinciding with low interest rates which have seen the Company make major acquisitions of The Optical Company ($43m) and Back in Motion ($88.4m) during the pandemic.

At an industry level, Healthia appears to be benefiting from its profile as a publicly listed Company, openly disclosing the 9.1% organic growth across the Group in FY21.

Coupled with the difficulties endured by small clinic owners, this has given rise to increased interest in Healthia within the fragmented podiatry, physiotherapy and optometry sectors as vendors seek to alleviate themselves of back-office responsibilities by joining the Healthia network.

This has driven the acceleration of Healthia’s network growth through the pandemic where the increase in clinic numbers have seen a similar trend in HLA’s share price. This additionally was highlighted over the past 12 months where HLA (+75%) has comfortably outperformed the Healthcare Index (+8.2%) and ASX 200 (+8.9%).

At what point might we expect Healthia’s growth to slow down?

Healthia has continued to re-iterate its commitment to deploying $20m per annum to acquisition growth which excludes their major acquisitions where they have raised fresh capital in order to fund.

Working in the favour of shareholders, Healthia has at no point since their IPO sought capital to fund this acquisition pipeline, rather capitalising on the low interest rates and increasing their finance facility from $50m in 2018 to $100m in 2021.

Following the acquisition of Back in Motion Group, Healthia still had $33m of headroom in this facility but with their rising revenues and organic earnings growth, more acquisitions each year are being funded from existing cash flow, whilst still issuing shareholders with a 2.8% dividend yield.

The competitive lending landscape has provided Healthia to twice re-finance their facilities which have been extended to 2024 which, coupled with their free cash flow, should see another three years of acquisition growth at $20m per annum deployed without the need for fresh capital.

  • About
  • Latest Posts
Jarryd Russell
Jarryd is an experienced Investment Adviser at Emerald Financial Group
Latest posts by Jarryd Russell (see all)
  • Number of allied health professionals rising - January 9, 2023
  • International Bank of Australia approved to launch Australia’s newest payments bank - November 7, 2022
  • Novatti partnership allows more businesses to accept payments on the go - October 31, 2022
*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications
  •  
  •  
  •  
  •  
  • Opinion

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Jarryd Russell
Jarryd is an experienced Investment Adviser at Emerald Financial Group
Latest posts by Jarryd Russell (see all)
  • Number of allied health professionals rising - January 9, 2023
  • International Bank of Australia approved to launch Australia’s newest payments bank - November 7, 2022
  • Novatti partnership allows more businesses to accept payments on the go - October 31, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Jarryd Russell
Jarryd is an experienced Investment Adviser at Emerald Financial Group
Latest posts by Jarryd Russell (see all)
  • Number of allied health professionals rising - January 9, 2023
  • International Bank of Australia approved to launch Australia’s newest payments bank - November 7, 2022
  • Novatti partnership allows more businesses to accept payments on the go - October 31, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.